NOT FOR DISTRIBUTION
Header cover image

Market Cap

€2.4b

Last Updated

2021/05/09 02:52 UTC

Data Sources

Company Financials +

Executive Summary

GVS S.p.A., together with its subsidiaries, produces and sells plastic filters and components for healthcare, life science, automotive, appliance, safety, and commercial and industrial filtration applications in Italy and internationally. More Details


Snowflake Analysis

Flawless balance sheet with outstanding track record.

Share Price & News

How has GVS's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: Insufficient data to determine GVSM's volatility over the past 3 months.

Volatility Over Time: Insufficient data to determine GVSM's volatility change over the past year.


Market Performance


7 Day Return

-0.6%

GVSM

1.7%

GB Medical Equipment

2.1%

GB Market


1 Year Return

n/a

GVSM

3.0%

GB Medical Equipment

26.5%

GB Market

Return vs Industry: Insufficient data to determine how GVSM performed against the UK Medical Equipment industry.

Return vs Market: Insufficient data to determine how GVSM performed against the UK Market.


Shareholder returns

GVSMIndustryMarket
7 Day-0.6%1.7%2.1%
30 Day3.1%12.5%3.3%
90 Day-12.9%5.4%9.1%
1 Yearn/a4.9%3.0%32.1%26.5%
3 Yearn/a25.4%18.3%12.8%-0.2%
5 Yearn/a47.8%35.6%51.7%23.0%

Long-Term Price Volatility Vs. Market

How volatile is GVS's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is GVS undervalued compared to its fair value and its price relative to the market?

39.3%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: GVSM (€14.44) is trading below our estimate of fair value (€23.79)

Significantly Below Fair Value: GVSM is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: GVSM is good value based on its PE Ratio (24x) compared to the GB Medical Equipment industry average (49.5x).

PE vs Market: GVSM is good value based on its PE Ratio (24x) compared to the UK market (26.1x).


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate GVSM's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: GVSM is overvalued based on its PB Ratio (7.7x) compared to the GB Medical Equipment industry average (3.8x).


Future Growth

How is GVS forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?

2.9%

Forecasted annual revenue growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if GVSM's forecast earnings growth is above the savings rate (0.9%).

Earnings vs Market: Insufficient data to determine if GVSM's earnings are forecast to grow faster than the UK market

High Growth Earnings: Insufficient data to determine if earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: GVSM's revenue (2.9% per year) is forecast to grow slower than the UK market (5.3% per year).

High Growth Revenue: GVSM's revenue (2.9% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if GVSM's Return on Equity is forecast to be high in 3 years time


Past Performance

How has GVS performed over the past 5 years?

48.0%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: GVSM has high quality earnings.

Growing Profit Margin: GVSM's current net profit margins (21.4%) are higher than last year (14.5%).


Past Earnings Growth Analysis

Earnings Trend: GVSM's earnings have grown significantly by 48% per year over the past 5 years.

Accelerating Growth: GVSM's earnings growth over the past year (135.5%) exceeds its 5-year average (48% per year).

Earnings vs Industry: GVSM earnings growth over the past year (135.5%) exceeded the Medical Equipment industry 13.8%.


Return on Equity

High ROE: GVSM's Return on Equity (32.2%) is considered high.


Financial Health

How is GVS's financial position?


Financial Position Analysis

Short Term Liabilities: GVSM's short term assets (€238.5M) exceed its short term liabilities (€85.7M).

Long Term Liabilities: GVSM's short term assets (€238.5M) exceed its long term liabilities (€84.0M).


Debt to Equity History and Analysis

Debt Level: GVSM's debt to equity ratio (36.8%) is considered satisfactory.

Reducing Debt: GVSM's debt to equity ratio has reduced from 135.1% to 36.8% over the past 5 years.

Debt Coverage: GVSM's debt is well covered by operating cash flow (127.6%).

Interest Coverage: GVSM's interest payments on its debt are well covered by EBIT (32.8x coverage).


Balance Sheet


Dividend

What is GVS current dividend yield, its reliability and sustainability?

0.95%

Current Dividend Yield


Dividend Yield vs Market

Notable Dividend: GVSM's dividend (0.95%) isn’t notable compared to the bottom 25% of dividend payers in the UK market (1.35%).

High Dividend: GVSM's dividend (0.95%) is low compared to the top 25% of dividend payers in the UK market (4.04%).


Stability and Growth of Payments

Stable Dividend: Too early to tell whether GVSM's dividend payments have been stable as they only just started paying a dividend.

Growing Dividend: Too early to tell if GVSM's dividend payments are increasing as they only just started paying a dividend.


Current Payout to Shareholders

Dividend Coverage: With its low payout ratio (22.8%), GVSM's dividend payments are well covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: GVSM is not forecast to pay a dividend in 3 years.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?


CEO

Massimo Scagliarini (55 yo)

no data

Tenure

Mr. Massimo Scagliarini serves as Chief Executive Officer and Director at GVS S.p.A. With over 35 years of experience, he has led the division operating in the medical sector and turn it into the most succ...


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: GVSM only recently listed within the past 12 months.


Top Shareholders

Company Information

GVS S.p.A.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: GVS S.p.A.
  • Ticker: GVSM
  • Exchange: BATS-CHIXE
  • Founded: 1979
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Market Cap: €2.394b
  • Shares outstanding: 175.00m
  • Website: https://www.gvs.com

Number of Employees


Location

  • GVS S.p.A.
  • Via Roma 50
  • Zola Predosa
  • Bologna
  • 40069
  • Italy

Listings


Biography

GVS S.p.A., together with its subsidiaries, produces and sells plastic filters and components for healthcare, life science, automotive, appliance, safety, and commercial and industrial filtration applicati...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/05/09 02:52
End of Day Share Price2021/05/04 00:00
Earnings2020/12/31
Annual Earnings2020/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.